Moneycontrol PRO
HomeNewsShasun pharma

Shasun Pharma

Jump to
  • Shasun Pharma consolidated Sep '15 sales at Rs 339.28 crore

    Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 339.28 crore and a net profit of Rs 13.09 crore for the quarter ended Sep '15

  • Shasun Pharma consolidated Jun '15 sales at Rs 333.57 crore

    Shasun Pharma consolidated Jun '15 sales at Rs 333.57 crore

    Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 333.57 crore and a net profit of Rs 3.80 crore for the quarter ended Jun '15

  • Shasun Pharma consolidated Mar '15 sales at Rs 357.95 crore

    Shasun Pharma consolidated Mar '15 sales at Rs 357.95 crore

    Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 357.95 crore and a net profit of Rs 22.16 crore for the quarter ended Mar '15

  • Nifty closes below 8550; Tata Motors drags, pharma rallies

    Nifty closes below 8550; Tata Motors drags, pharma rallies

    It was another consolidation day for the market on Tuesday with the Nifty gyrating in a 100-point band but it finally ended flat. Banks continued to see selling pressure while pharma and oil stocks saw buying interest.

  • Nifty reclaims 8600; Shasun Pharma surges, Aarti Drugs down

    Nifty reclaims 8600; Shasun Pharma surges, Aarti Drugs down

    The market maintained its uptrend amid volatility. The Sensex rose 107.58 points to 28299.60 and the Nifty climbed 33.50 points to 8584.40.

  • Shasun Pharma consolidated Dec '14 sales at Rs 325.00 crore

    Shasun Pharma consolidated Dec '14 sales at Rs 325.00 crore

    Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 325.00 crore and a net profit of Rs 6.14 crore for the quarter ended Dec '14

  • Shasun Pharma consolidated Dec '13 sales at Rs 325.28 crore

    Shasun Pharma consolidated Dec '13 sales at Rs 325.28 crore

    Shasun Pharmaceuticals has reported a sales turnover of Rs 325.28 crore and a net profit of Rs 13.04 crore for the quarter ended Dec '13

  • Buy Den Networks, Sadbhav Engg, Shasun Pharma: Kunal Bothra

    Buy Den Networks, Sadbhav Engg, Shasun Pharma: Kunal Bothra

    Kunal Bothra of LKP recommends buying Den Networks with a target of Rs 169 and suggets buying Arvind.

  • Check out: Buzzing small cap stocks on November 11

    Check out: Buzzing small cap stocks on November 11

    Here's how small cap stocks opened on November 11

  • Buzzing small cap stocks on November 6

    Buzzing small cap stocks on November 6

    Here's how small cap stocks opened on November 6

  • Check out: Buzzing small cap stocks on October 9

    Check out: Buzzing small cap stocks on October 9

    Here's how small cap stocks opened on October 9

  • Here's how small cap stocks opened on October 8

    Here's how small cap stocks opened on October 8

    Here's how small cap stocks opened on October 8

  • Buzzing small cap stocks open on September 27

    Buzzing small cap stocks open on September 27

    Here's how small cap stocks opened on September 27

  • Check out: Buzzing small cap stocks on September 13

    Check out: Buzzing small cap stocks on September 13

    Here's how small cap stocks opened on September 13

  • Infosys, Dabur, Biocon to get astrological support: Gupta

    Infosys, Dabur, Biocon to get astrological support: Gupta

    According to Satish Gupta of astrostocktips.in, technology stocks like Infosys, TCS and HCL Technologies will get astrological support.

  • Shasun Pharma consolidated Jun '13 sales at Rs 227.27 crore

    Shasun Pharma consolidated Jun '13 sales at Rs 227.27 crore

    Shasun Pharmaceuticals has reported a sales turnover of Rs 227.27 crore and a net loss of Rs 6.57 crore for the quarter ended Jun '13

  • Stocks in news: Tata Steel, IOC, SpiceJet, Polaris, NHPC

    Stocks in news: Tata Steel, IOC, SpiceJet, Polaris, NHPC

    Reliance Industries | Tata Steel | IOC | Kalindee Rail | Crompton Greaves | Managalore Chemicals | Tech Mahindra | Polaris | NHPC | ICICI Bank | SpiceJet | Glenmark Pharma | Sadbhav Engineering | Shasun Pharma | Colgate Palmolive and Cipla are stocks, which are in the news today.

  • Stocks in news: Shasun, DCHL, GRUH Finance, Educomp, Maruti

    Stocks in news: Shasun, DCHL, GRUH Finance, Educomp, Maruti

    Sundaram-Clayton | Kalindee Rail | Shasun Pharma | Deccan Chronicle Holdings | GRUH Finance | Educomp Solutions | Jet Airways and Maruti Suzuki are stocks, which are in the news today.

  • Buy Dewan Housing, Shasun Pharma, Kalpataru Power: Lancelot

    Buy Dewan Housing, Shasun Pharma, Kalpataru Power: Lancelot

    Lancelot D Cunha of Sharyans Wealth Management recommends to buy Dewan Housing Finance Corporation with a target price of Rs 164.10 and Shasun Pharma with a target price of Rs 55.80.

  • Bull's Eye: Buy UCO Bank, Indiabulls Real, Kalpataru Power

    Bull's Eye: Buy UCO Bank, Indiabulls Real, Kalpataru Power

    Aashish Tater of Fortunewizard.com advises buying Siti with a target price of Rs 22 and Dena Bank with a target price of Rs 74.

  • Shasun Pharma shares plunge 8%

    Shasun Pharma shares plunge 8%

    Shasun Pharma's shares fell 8 percent on the back of the company's operations at its Puducherry plant being affected by the strike called by the workers. The stock fell 13.14 percent to 52-week low of Rs 55.50 in intra-day trade on the BSE.

  • Sensex, Nifty flat in volatile trade; ONGC tops loser list

    Sensex, Nifty flat in volatile trade; ONGC tops loser list

    Key equity benchmarks continued to trade volatile, with the Nifty struggling to hold the 5500 mark, pulled lower by commodity and FMCG stocks.

  • Shasun Pharma in licensing pact with Debiopharm Group

    Shasun Pharma in licensing pact with Debiopharm Group

    Chennai-based Shasun Pharmaceuticals has entered into a licensing agreement with Swiss biopharmaceutical group Debiopharm for the manufacturing and commercialization of Huperzine-A, sending its shares up over 4 percent.

  • Cautious on Tata Motors; short Opto Circuits, HDIL: Tulsian

    Cautious on Tata Motors; short Opto Circuits, HDIL: Tulsian

    In an interview to CNBC-TV18 on SP Tulsian, sptulsian.com shared his reading and outlook on stocks and sectors. With regards to Tata Motors he said, "I will keep a cautious view and will not keep my long positions open for tomorrow."

  • Avoid Dishman Pharma, says SP Tulsian

    Avoid Dishman Pharma, says SP Tulsian

    SP Tulsian, sptulsian.com don‘t think that Dishman Pharma can correct below Rs 84-85. He feels the major correction seems to have got factored in. However, he still feels one should not invest in Dishman Pharma even at current levels.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347